Connect With a Global Community of Experts
For 11 years, the 3D Tissue Models Summit has cultivated a community tackling complex in vitro model validation, reproducibility, and scalability head-on. But biopharma teams have returned because these challenges demand collaboration between end-users and solution providers.
We've built a focused environment where drug discovery, in vitro pharmacology, toxicology, and preclinical development experts engage in specialized, actionable discussions. Every conversation matters because attendees are here to solve specific problems.
With the Senate clearing the FDA Modernization Act 3.0, and the FDA publishing their roadmap away from animal models, biopharma are actively searching for support. This includes expertise from complex in vitro model providers, 3D bioprinters, specialized imaging systems, and software vendors who can deliver translatable solutions for this new regulatory landscape.
Join the collective effort to increase leadership buy-in of complex in vitro models with Merck, AstraZeneca, Pfizer, Takeda, Vertex Pharma and more. There’s so much potential yet be discovered with 3D Tissue Models.
What to Expect?
Meet Decision-Makers Already Looking for You
Access an audience curated over 11 years, heads of complex modeling departments seeking new partnerships or nurture existing relationships.
Establish Your Presence in the 3D Tissue Modeling Space
Position your company directly in front of the experts developing, optimizing, and implementing organoids, spheroids, and MPS technologies.
Model Your Services Around Real Challenges
Stay ahead by learning the latest validation, translatability, and reproducibility hurdles, then demonstrate how your solutions address them.
Distinguish Yourself from the Crowd
With limited partnership opportunities, stand out by engaging with an exclusive community of 3D tissue modeling experts from the US and Europe in an intimate, focused setting.
Key Services & Solutions
Our attendees of complex in vitro modelling experts are looking for service and solution providers with capabilities in the below areas but not limited to:
- Complex in vitro modeling CROs
- Software and Imaging
- 3D Bioprinters
Hear What Our Past Sponsors Have to Say
Fantastic scientific discussion, led by knowledgeable session chairs. The roundtable discussions allowed wider participation from the entire audience
Molecular Devices LLC
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Eleni Topollaj
Partnerships Director